awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36040002-EBD6692D-2F05-4ABA-A15C-3CE2A981EDC7
Q36040002-EBD6692D-2F05-4ABA-A15C-3CE2A981EDC7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36040002-EBD6692D-2F05-4ABA-A15C-3CE2A981EDC7
Epidermal Growth Factor Receptor Mutation (EGFR) Testing for Prediction of Response to EGFR-Targeting Tyrosine Kinase Inhibitor (TKI) Drugs in Patients with Advanced Non-Small-Cell Lung Cancer: An Evidence-Based Analysis
P2860
Q36040002-EBD6692D-2F05-4ABA-A15C-3CE2A981EDC7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36040002-EBD6692D-2F05-4ABA-A15C-3CE2A981EDC7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
61066aa40395554b1c5534f4347278196ae67e9e
P2860
Phase II randomised trial comparing docetaxel given every 3 weeks with weekly schedule as second-line therapy in patients with advanced non-small-cell lung cancer (NSCLC).